Comparison of Ropivacaine and Bupivacaine Toxicity in Human Articular Chondrocytes
- 1 May 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 90 (5) , 986-991
Abstract
Background: It has been shown that bupivacaine, the most commonly used local anesthetic for postoperative intra-articular use, is cytotoxic to bovine articular chondrocytes in vitro. Ropivacaine is as effective as bupivacaine for intra-articular analgesia and has less systemic toxicity. We compared the in vitro viability of human articular chondrocytes after exposure to bupivacaine, ropivacaine, and saline solution control. Methods: Macroscopically normal human articular cartilage was harvested from the femoral head or tibial plateau of five patients. Full-thickness cartilage explants and cultured chondrocytes isolated from these patients were treated with 0.9% normal saline solution, 0.5% ropivacaine, or 0.5% bupivacaine for thirty minutes. Twenty-four hours after treatment, chondrocyte viability was measured with use of the LIVE/DEAD Viability/Cytotoxicity Kit for cartilage explants and with use of the CellTiter-Glo Luminescent Cell Viability Assay for cultured chondrocytes. Results: Chondrocyte viability in cartilage explants was significantly greater after treatment with ropivacaine as compared with bupivacaine (94.4% ± 9.0% compared with 78% ± 12.6%; p = 0.0004). There was no difference in viability after treatment with ropivacaine as compared with saline solution (94.4% ± 9.0% compared with 95.8% ± 5.7%; p = 0.6). The viability of cultured chondrocytes was significantly greater after treatment with ropivacaine as compared with bupivacaine (63.9% ± 19% as compared with 37.4% ± 12% of the value in the saline solution group; p < 0.0001). Conclusions: In vitro, 0.5% ropivacaine is significantly less toxic than 0.5% bupivacaine in both intact human articular cartilage and chondrocyte culture. Clinical Relevance: Although bupivacaine is the most commonly used local anesthetic for intra-articular analgesia, the demonstrated toxicity to human articular chondrocytes is cause for concern. The present study demonstrated that ropivacaine is less chondrotoxic than bupivacaine and, therefore, may be safer for intra-articular analgesia.Keywords
This publication has 15 references indexed in Scilit:
- Chondrolysis After Continuous Intra‐Articular Bupivacaine Infusion: An Experimental Model Investigating Chondrotoxicity in the Rabbit ShoulderArthroscopy, 2006
- In Vitro Exposure to 0.5% Bupivacaine Is Cytotoxic to Bovine Articular ChondrocytesArthroscopy, 2006
- Intra‐articular ropivacaine 0.75% and bupivacaine 0.50% for analgesia after arthroscopic knee surgery: A randomized prospective studyArthroscopy, 2005
- The Effects of Bupivacaine and Neostigmine on Articular Cartilage and Synovium in the Rabbit Knee JointJournal of International Medical Research, 2004
- The effects of morphine on human articular cartilage of the kneeArthroscopy, 2002
- A systematic review of intra-articular local anesthesia for postoperative pain relief after arthroscopic knee surgeryRegional Anesthesia & Pain Medicine, 1999
- A Systematic Review of Intra-articular Local Anesthesia for Postoperative Pain Relief After Arthroscopic Knee SurgeryRegional Anesthesia & Pain Medicine, 1999
- Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitroInflammation Research, 1997
- RopivacaineBritish Journal of Anaesthesia, 1996
- Bupivacaine and saline effects on articular cartilageArthroscopy, 1985